The global digestive system drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor contributing to the growth of the market during the forecast period is the increasing prevalence of gastrointestinal diseases. This disease is caused due to unhealthy dietary habits. Furthermore, the market is also growing due to rising numbers of clinical trials as well as the increasing healthcare expenditure along with the increasing prevalence of geriatric population.
Digestive diseases include gastrointestinal disorders such as irritable bowel syndrome (IBS), constipation, among others. The market is growing owing to new FDA approvals. For instance, in June 2019, FDA approved Ibsrela, a 50 mg, twice-daily oral therapy for irritable bowel syndrome with constipation in adults. Additionally, in June 2019, FDA permitted the marketing of the first medical device to aid in the reduction of functional abdominal pain. It is used for the treatment of patients 11-18 years of age with irritable bowel syndrome (IBS).
To Request a Sample of our Report on Digestive System Drugs Market: https://www.omrglobal.com/request-sample/digestive-system-drugs-market
Some major players in the market include Abbott Laboratories, AbbVie Inc., and Bayer AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Knight Therapeutics Inc. announced the commercial availability of IBSRELA (tenapanor) in Canada. It is a therapy used for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drug Type
- By Dosage Form
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Abbott Laboratories, AbbVie Inc., and Bayer AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Digestive System Drugs Market is Available @ https://www.omrglobal.com/industry-reports/digestive-system-drugs-market
Global Digestive System Drugs Market Report by Segment
By Drug Type
- Antacids
- Laxatives
- Antidiarrheal agents
- Antiemetics
- Antiulcer agents
- Other
By Dosage Form
- Oral
- Parenteral
- Other
By Application
- Ulcerative Colitis
- Irritable Bowel Syndrome
- Crohn’s Disease
- Celiac Disease
- Gastroenteritis
- Other
Global Digestive System Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
